Examination of tumor board adherence from the Interdisciplinary Tumor Conference of the Lung Cancer Center Freiburg

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020278

Enrollment

226

Registered

2020-03-24

Start date

2020-02-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: A total of 272 cases presented at the Tumour Conference of the Freiburg Lung Cancer Centre in the period from January to March 2018 will be examined to see whether the decisions made at the T

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: all 226 patients presented at the interdisciplinary tumour conference of the Lung Cancer Centre Freiburg from January to March 2018

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Review of the percentage of adherence of tumour board decisions in diagnostics and therapy from 01-03/ 2018	—

Secondary

Measure	Time frame
Checking whether the tumor board decisions are recommendations for further diagnosis or recommendations regarding therapy and whether there are differences in adherence between the two groups. In addition, it is to be found out how the frequency of presentation of the individual patient turns out, whether the procedures suggested at the time of registration are modified by the Tumour Board and how many patients have been included in clinical studies.	—

Measure

Time frame

Checking whether the tumor board decisions are recommendations for further diagnosis or recommendations regarding therapy and whether there are differences in adherence between the two groups. In addition, it is to be found out how the frequency of presentation of the individual patient turns out, whether the procedures suggested at the time of registration are modified by the Tumour Board and how many patients have been included in clinical studies.

—

Countries

Germany

Contacts

Public ContactTabea Wagner

Klinik für Thoraxchirurgie Universitätsklinikum Freiburg

tabea.wagner@uniklinik-freiburg.de0761 27024720

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026